Cargando…
Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer
STAT3 overactivation is a common event in many cancers, including head and neck squamous cell carcinoma (HNSCC), where STAT3 represents a promising therapeutic target. HNSCC is not characterized by frequent kinase mutations, in contrast to some malignancies where mutational activation of kinases ups...
Autores principales: | Peyser, Noah D., Freilino, Maria, Wang, Lin, Zeng, Yan, Li, Hua, Johnson, Daniel E., Grandis, Jennifer R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4651851/ https://www.ncbi.nlm.nih.gov/pubmed/25982282 http://dx.doi.org/10.1038/onc.2015.171 |
Ejemplares similares
-
Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer
por: Peyser, Noah D., et al.
Publicado: (2015) -
Genomic and Transcriptomic Alterations Associated with STAT3 Activation in Head and Neck Cancer
por: Peyser, Noah D., et al.
Publicado: (2016) -
Critical analysis of the potential for targeting STAT3 in human malignancy
por: Peyser, Noah D, et al.
Publicado: (2013) -
JAK Kinase Inhibition Abrogates STAT3 Activation and Head and Neck Squamous Cell Carcinoma Tumor Growth()()
por: Sen, Malabika, et al.
Publicado: (2015) -
NSAIDs Overcome PIK3CA Mutation-Mediated Resistance to EGFR Inhibition in Head and Neck Cancer Preclinical Models
por: Li, Hua, et al.
Publicado: (2022)